stringtranslate.com

Oswaldo Cruz Foundation

22°52′29.57″S 43°14′43.58″W / 22.8748806°S 43.2454389°W / -22.8748806; -43.2454389

Façade of the Neo-Mouresque Palace of Manguinhos, site of the Instituto Oswaldo Cruz in Rio de Janeiro.

The Oswaldo Cruz Foundation (Portuguese Fundação Oswaldo Cruz, also known as FIOCRUZ) is a scientific institution for research and development in biological sciences located in Rio de Janeiro, Brazil; it is considered one of the world's main public health research institutions. It was founded by Dr. Oswaldo Cruz, a noted physician and epidemiologist.

History

The organization started in 1898 as the Federal SeroTherapy Institute with the objective of developing serum and vaccines against the bubonic plague.[1] It was located outside Rio de Janeiro.[1] The institute's activities, however, changed from simple production into research and experimental medicine, especially after Oswaldo Cruz assumed its leadership in 1902. From there on, the institute became the base for memorable sanitation campaigns in an age of outbreaks and epidemics of the bubonic plague, yellow fever, and smallpox. The institute, however, was not confined to Rio de Janeiro and collaborated in the occupation of the country's interior through scientific expeditions, aiding in the development of the country.

When Oswaldo Cruz died in 1917, the institute, which by then already bore his name, was nationally consolidated and important scientific achievements followed, such as Carlos Chagas’ description of the complete cycle of the American trypanosomiasis including the clinical pattern of the disease.

Today the institution has a broad range of responsibilities related to the health and wellbeing of the Brazilian population, functioning as a national institute of health for the Brazilian government. These responsibilities include

La plantilla de Fiocruz cuenta con más de 7.500 personas. Fiocruz incluye varias instalaciones fijas en Río de Janeiro y otras localidades; sin embargo, contribuye a mejorar la salud en todo el país, a través de su apoyo al Sistema Único de Salud (Sistema Único de Salud, el sistema público de salud brasileño), sus propuestas sobre la formulación de políticas de salud pública, sus actividades de investigación, sus expediciones científicas y el alcance de sus servicios y productos de salud.

Fiocruz es uno de los miembros fundadores de la Asociación Internacional de Institutos Nacionales de Salud Pública , una organización miembro de los institutos nacionales de salud pública . [2] La fundación tiene una colaboración de larga data con GISAID , analizando y curando datos del virus COVID-19 en las Américas, y luego contribuyen rápidamente con esas secuencias genéticas al repositorio. [3] [4]

Ver también

Referencias

  1. ^ ab "Historia de Fiocruz Minas - Centro de Pesquisas René Rachou". www.cpqrr.fiocruz.br . Consultado el 3 de febrero de 2016 .
  2. ^ "Historia". www.ianphi.org . IANPHI. Archivado desde el original el 28 de abril de 2013 . Consultado el 4 de agosto de 2014 .
  3. ^ Ferreira, Vinicius. "Fiocruz integra plataforma de datos genómicos sobre influenza y nuevo coronavirus". Fiocruz . Fundación Oswaldo Cruz . Consultado el 16 de agosto de 2021 .
  4. ^ Khalik, Salma (15 de enero de 2021). "Superando su peso en la lucha global contra Covid-19". Los tiempos del estrecho . Noticias digitales de Singapore Press Holdings Ltd. Co. SPH . Consultado el 16 de agosto de 2021 .

enlaces externos